Navigation Links
ProSolv CardioVascular and GE Healthcare Ultrasound Division Announce Affiliation
Date:3/29/2009

Companies to collaborate on product development to create open access to information that will enhance workflow and increase clinician efficiencies

ORLANDO, Fla., March 29 /PRNewswire/ -- ProSolv CardioVascular, a FUJIFILM company and GE Healthcare's Cardiovascular Ultrasound unit announced a formal affiliation under which the companies will work collaboratively to develop an integrated solution aimed at improving workflow for echocardiography departments. Specifically, the organizations hope to expand user access to the advanced quantitative analysis packages currently offered through GE Healthcare by offering workflow and diagnostic reporting efficiencies.

GE Healthcare currently provides an advanced analysis and quantification software module, EchoPAC, specifically designed for the analysis of raw data image sets from GE Healthcare cardiovascular ultrasound systems. Through the new affiliation, GE Healthcare and ProSolv CardioVascular intend to help make information more universally accessible by cardiologists and other clinical staff by working to assure that, no matter where the information is accessed, users have virtually the same level of advanced diagnostic functionality. In doing so, the companies believe users could benefit from a quicker diagnostic process and enhanced diagnostic confidence.

"We're pleased to be working with GE with the aim to deliver advanced integrations that will provide diagnostic and workflow efficiency improvements to our mutual customers," said Aaron Waitz, President and CEO, ProSolv CardioVascular. "There is a definite need for more open access to data throughout cardiovascular departments and healthcare systems as a whole. By leveraging our vendor-neutral solution, we'll aim to provide unlimited access to state of the art ultrasound advanced clinical applications, taking one more step forward on the quest to improve the vital exchange of healthcare information," continued Waitz.

"By providing our ProSolv customers access to raw data analysis and quantitative features of EchoPAC, we could help more customers improve their diagnostic and analysis capabilities and improve patient care," said Al Lojewski, Vice President and General Manager of GE's Cardiovascular Ultrasound unit. "When we do that, we're working toward creating a healthier and more affordable system for patients everywhere."

About ProSolv CardioVascular, a FUJIFILM Company

Founded in 1989 as Problem Solving Concepts, Inc. ("ProSolv") and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions consist of advanced reporting and image management software, comprehensive support services and integration with third-party clinical applications. The Synapse ProSolv(R) cardiovascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers' return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana. For more information visit the ProSolv CardioVascular website at www.prosolv.com.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

(C) 2009 ProSolv CardioVascular, a FUJIFILM Company


'/>"/>
SOURCE ProSolv CardioVascular
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ProSolv Releases New Cardiovascular Software
2. MSU researcher links cholesterol crystals to cardiovascular attacks
3. Momentum Women(TM) Honors Patricia Scheller of Prescient Medical for Commitment to Promoting Cardiovascular Disease Awareness
4. New Cardiovascular and Orthopaedic Content Pushes Materials for Medical Devices Database to Milestone
5. Employee cardiovascular health relates to psychological well-being
6. Greenway Medical Technologies Continues Fast-Paced Growth With Addition of Cardiovascular Specialty Associates of North Texas (CSANT)
7. New research suggests common anti-seizure medications may increase risk of cardiovascular problems
8. EuroPRevent 09: Changing hearts and minds in the drive to prevent cardiovascular disease
9. Nurses and allied professionals at heart of cardiovascular prevention and management programs
10. CorMatrix Cardiovascular Announces First European Implants of CorMatrix(R) ECM Technology(TM)
11. Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of Happy ... their novel lifesaving device for the everyday use of parents worldwide. It is ... to read a child’s vital signs, and detect unusual symptoms or physical patterns. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the Renaissance ... program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish we ... entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. Ted ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, ... neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it ... as the product advances towards regulatory and clinical phases. , "This is another ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Viverae ® , a leader in workplace ... IBM ® Watson Campaign Automation, implementing behavioral messaging ... a personalized experience. Through digital engagement, the platform prompts ... real time. The enhanced experience drives engagement by focusing ... they are in their journey to health. ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
(Date:4/18/2017)... April 18, 2017  Socionext Inc. and SOINN ... in 2016, in which Socionext extracts and delivers ... companies achieved initial results in reading ultrasound images ... Brain SOINN. The results will be introduced at ... 19-21, at booths 4505 & 4507. ...
Breaking Medicine Technology: